Skip to content

DR. GUDRUN DECONINCK

Active
Private limited companyfounded 2021active for 5 yearsJonkheer Paul Coppietersdreef 24, 8200 Brugge, BelgiumKBO/BCE: BE 0760.960.248
Summary

DR. GUDRUN DECONINCK has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,000 and a net result of €15,664. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 14% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 07-01-2021 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.311.966.690 8200 Brugge, since 07-01-2021
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board
  • Deconinck GudrunDirector · since 07-01-2021

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€39,910
▼ 19.5%
Turnover
≈ €120,000
estimated
Profit
€15,664
▼ 25.2%
Equity
€5,000
▼ 80.7%
Total assets
€51,475
▼ 40.3%
Staff
≈ 0 FTE
estimated
Filed on 12-05-2026, 80 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €51,475Liquidity: current ratio 0.69, cash €11,976, halvedFigures for financial year 2025 (filed on 12-05-2026)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 28% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 35-20
equity 9.7% of total assets
Liquidity 39-37
short-term debt 73.6% · cash 23.3%
Profitability 100+1
return on assets 30.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 14% of them on solvency, 9% on liquidity, 80% on profitability and 7% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €51,475
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.69, cash €11,976, halved
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 12-05-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 14%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-05-2026, 80 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
80 days early
2024
17 days early
2023
42 days early
2022
7 days early
2021
22 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 25 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 July (4 of the last 5 accounts filed within 39 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Less equity than 91% of companies in human healthsector median €124,659 · 20,702 companies €5,000 View
  • Positive: 5 profitable years in a rowprofit 2025: €15,664 5 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed Incorporation
All 8 events

Comparable companies

These companies have the same main activity as DR. GUDRUN DECONINCK: general medical practice (NACE 86210). They are comparable in size and age: total assets between €49,300 and €56,800, founded between 2019 and 2021.

CompanyTotal assetsGross margin
DR. GUDRUN DECONINCK Brugge€51,475€39,910
Dr. Elien Gheysens Brugge€56,096€39,982
Dr. ISABELLE THEETAERT Brugge€52,833€42,812
Dokter Annelies Deschepper, Huisarts Asse€49,327€37,850
SECRETIN.MED Elsene€52,439€39,869
Dokter Dirk Asselman, huisarts Oudenaarde€56,754€40,127
Dr. Jolien Decroo - huisarts Kortrijk€52,833€49,160
Full comparison

Key facts about DR. GUDRUN DECONINCK

What is the company number of DR. GUDRUN DECONINCK?
The company number of DR. GUDRUN DECONINCK is 0760.960.248. The VAT number is the same number with BE in front: BE 0760.960.248.
Where is DR. GUDRUN DECONINCK based?
The registered office is at Jonkheer Paul Coppietersdreef 24, 8200 Brugge.Company details
What does DR. GUDRUN DECONINCK do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. GUDRUN DECONINCK?
The legal form of DR. GUDRUN DECONINCK is Private limited company (BV).
When was DR. GUDRUN DECONINCK founded?
DR. GUDRUN DECONINCK was founded on 07-01-2021.
Is DR. GUDRUN DECONINCK still active?
Yes, DR. GUDRUN DECONINCK is an active enterprise in the KBO register.
What is the turnover of DR. GUDRUN DECONINCK?
The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €39,910 and 47 comparable companies (NACE 86). It probably lies between €88,000 and €170,000.Financials
Is DR. GUDRUN DECONINCK profitable?
In financial year 2025, DR. GUDRUN DECONINCK made a profit of €15,664.
Where can I find the annual accounts of DR. GUDRUN DECONINCK?
DR. GUDRUN DECONINCK filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. GUDRUN DECONINCK due?
DR. GUDRUN DECONINCK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.